| AVICANNA INC. |
| Kanada |
| Gesundheit |
| CA05368K1003 / A2PN04 |
| 0NN (Frankfurt) |
| FRA:0NN, ETR:0NN, 0NN:GR |
| - |
| http://www.avicanna.com/ |
|
Avicanna Inc. is a leading Canadian biopharmaceutical company specializing in the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The company focuses on delivering innovative health solutions through its..
>Volltext.. |
| 11.74 Mio. EUR |
| 16.71 Mio. EUR |
| 15.86 Mio. EUR |
| -1.27 Mio. EUR |
| -1.16 Mio. EUR |
| -0.01 EUR |
| - |
| 0.29 Mio. EUR |
| -0.77 Mio. EUR |
| 0.05 |
| -5.6% |
| 71.28% |
| - |
| - |
| - |
| - |
| AVICANNA |
| 05.04.26 |
|